Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

503 public trials 139 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma

NCT00394693

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Northwestern University Medical School Chicago, Illinois, United States
  • M.D. Anderson Cancer Center Houston, Texas, United States
  • Hopital Lapeyronie Montpellier, France
View Trial Details
Completed

Safety of PCI-32765 in Chronic Lymphocytic Leukemia

NCT01105247

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • New York Presbyterian Hosptial Cornell Med Center New York, United States
  • The Ohio State University Columbus, Ohio, United States
  • Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States
View Trial Details
Completed

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

NCT00849654

Conditions
B-cell Leukemia, B-cell Lymphoma, Blood Protein Disorders, +31 more
Locations
  • Stanford University School of Medicine Palo Alto, California, United States
  • University of Chicago Chicago, Illinois, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • New York Prebyterian Hospital Cornell Medical Center New York, United States
View Trial Details
Completed

SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma

NCT00796731

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Sanofi-Aventis Investigational Site Number 250004 Créteil, France
  • Sanofi-Aventis Investigational Site Number 250006 Lille, France
  • Sanofi-Aventis Investigational Site Number 250001 Pierre-Bénite, France
  • Sanofi-Aventis Investigational Site Number 250005 Rennes, France
View Trial Details

Related conditions